Jane Street »

Akari Therapeutics Plc Sponsored shares owned by Jane Street

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $21k 72k 0.29

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Warberg Asset Management
Palo Alto Investors
HighTower Advisors
Jane Street
CWA Asset Management
XTX Topco
UBS Group
HPM Partners
Intl Fcstone
Skyview Financial Group
Independent Advisor Alliance
Goss Wealth Management
Accent Capital Management
SBI Securities

View all funds holding Akari Therapeutics Plc Sponsored